These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1950285)

  • 1. [The protective properties of the endotoxin protein].
    Levenson VI; Belkin ZP; Egorova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):5-9. PubMed ID: 1950285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunogenic properties of the endotoxin protein: serum antibodies in animals and man].
    Belkin ZP; Egorova TP; Nartikova VF; Fedosova VG; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):73-6. PubMed ID: 1719717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants].
    Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Shigella endotoxin protein--its electrophoretic and serological properties].
    Nartikova VF; Egorova TP; Belkin ZP; Fedosova VG; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):14-7. PubMed ID: 1882599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp.
    Adamus G; Mulczyk M; Witkowska D; Romanowska E
    Infect Immun; 1980 Nov; 30(2):321-4. PubMed ID: 7002794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ribosomal dysentery vaccine. II. Biological trials of active protection for guinea pigs and mice].
    Levinson VI; Subbotina IuL
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):81-6. PubMed ID: 358702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of the synergistic action of enterotoxin on the specific protective complex of Shigella sonnei].
    Korneeva SA; Kovalevskaia IL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):38-41. PubMed ID: 1789032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic properties of soluble shigella antigens].
    Gorbunova ES; Stepanova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):58-63. PubMed ID: 335736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenic properties of Shigella sonnei neurotoxin].
    Kamzolkina NB
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):71-5. PubMed ID: 4590986
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the immunogenicity of neurotoxin preparations and their separate fractions obtained from Shigella sonnei, phases I and II].
    Kamzolkina NB; Iarovaia LM
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):23-6. PubMed ID: 6367318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunogenic and serological properties of the O-specific polysaccharide (L-hapten) in Shigella].
    Levenson VI; Belkin ZP; Egorova TP; Liubinskaia MM; Sazykina SIu
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):25-9. PubMed ID: 1719715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.
    Levenson VI; Egorova TP; Belkin ZP; Fedosova VG; Subbotina JL; Rukhadze EZ; Dzhikidze EK; Stassilevich ZK
    Infect Immun; 1991 Oct; 59(10):3610-8. PubMed ID: 1716612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the keratoconjunctival model in guinea pigs for quantitative assessment of the immunogenicity of dysentery antigens].
    Korneeva SA; Solov'eva OG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):139-40. PubMed ID: 335731
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological properties of a ribosomal vaccine from S. sonnei obtained by polyethylene glycol fractionation].
    Levenson VI; Rukhadze EZ; Fedosova VG; Dzhikidze EK; Stasilevich ZK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):77-81. PubMed ID: 6395593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.